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ABSTRACT
Objective: Hand assist laparoscopic surgery (HALS) is a
surgical modality rarely used in benign gynecology. We
analyzed nonmalignant pelvic disorders that utilized HALS
to see whether there is any benefit over standard laparot-
omy.
Methods: A case control chart review identified patients
who underwent HALS for a variety of benign gynecolog-
ical conditions from 2004 through 2007. Cases were then
compared with a control group of all the patients who
underwent similar procedures for the same diagnosis via
laparotomy (ELAP) in our center within the same time
period. The groups were comparable with respect to age,
BMI, and surgical indication.
Results: Twenty-nine patients were analyzed: 12 cases
(HALS) and 17 controls (ELAP). Each group was broken
up into 2 subsets: Group A, older patients who underwent
surgery for pelvic organ prolapse or diverticulitis with
adnexectomy and Group B, younger patients who under-
went surgery for pelvic pain, endometriosis, or both. Hos-
pital stay in Group B was statistically lower in the HALS
cases vs. the ELAP controls, (2.9 vs. 5.4 days, P0.04). All
HALS and ELAP patients were then analyzed for overall
trends. HALS cases had shorter hospitalization than ELAP
controls had (3.3 vs 4.5 days, P0.035). Estimated blood
loss was also less overall in the HALS cases vs. the ELAP
controls (175 vs 355.9 mL, P0.021). There were 2 ad-
verse outcomes reported in Group A of the HALS cases.
These 2 patients experienced postoperative hernias
though the hand-assist port-site incision.
Conclusion: Compared with laparotomy, overall, HALS
offers the advantage of decreased hospitalization and de-
creased intraoperative blood loss. Postoperative hernias
through the HA port site may be a potential problem with
this technique.
Key Words: Hand assist laparoscopy, Pelvic surgery, Pel-
vic pain.
INTRODUCTION
Gynecologists have long discussed the benefits of laparo-
scopic surgery including shorter hospital stay, decreased
postoperative pain, improved cosmesis, and faster return
to normal activities. Occasionally, situations arise that cre-
ate technical challenges even for skilled laparoscopists.
Hand assist laparoscopic surgery (HALS) was developed
in the early 1990s to prevent conversion from minimally
invasive surgery to an open procedure.1 HALS allows for
the placement of the surgeon’s nondominant hand
through a hand-port device while maintaining pneumo-
peritoneum (Figure 1). The intraabdominal hand works
in conjunction with the traditional laparoscopic instru-
ments manipulated by the surgeon’s dominant hand.
HALS essentially combines the superior visualization pro-
vided by the laparoscope with the tactile sensation of an
open procedure. It allows for blunt dissection, superior
hemostasis, organ retraction, and avoids the necessity for
morcellation of solid organs. Published data2–4 in the
general surgery literature demonstrates that HALS is a safe
and valid surgical approach for colectomies, splenecto-
mies, and nephrectomies. When compared with tradi-
tional laparotomy, these studies report decreased blood
loss, length of hospital stay, morbidity, and a faster recov-
ery period.
Several gynecologic studies have looked at HALS in the
evaluation of adnexal masses and gynecologic cancers.5–9
These reports have concluded that the HALS approach
provides thorough evaluation of peritoneal and retroper-
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SCIENTIFIC PAPERitoneal structures as well as cytoreduction while maintain-
ing the benefits of minimally invasive surgery. Pelosi11
published case reports about the use of HALS for complex
hysterectomy in 1999. However, studies using HALS in
benign gynecology are scarce.10,11 Our goal was to review
nonmalignant pelvic surgery cases where HALS was used
at our institution to see whether there is any benefit over
standard laparotomy. We also hope to present some situ-
ations that gynecologists encounter where HALS may be a
viable minimally invasive alternative to converting to lap-
arotomy.
METHODS
After obtaining IRB approval, a records search in a pelvic
surgery referral center identified 14 patients who under-
went a HALS procedure between 2004 and 2007. Two
patients who received HALS via a midline vertical incision
were excluded to maintain a uniform comparison. Record
review of the remaining 12 HALS patients identified the
indication and the operative procedures performed. A
second review then identified a control group of 17 pa-
tients who underwent similar procedures for the same
indication via traditional open laparotomy during the
same period.
Information about patient demographics, surgical indica-
tions, procedures, estimated blood loss, postoperative
drop in hematocrit, operative time, average pain scores,
length of hospital stay, and complications were abstracted
from each chart. Pain scores were patient reported and
nurse recorded using a Visual Analog Scale (VAS) pain
scale. Data were expressed using means with standard
deviations. Univariate analysis used the Mann-Whitney U
Test and Fisher’s Exact Test with significance set at
P0.05.
Two subgroups of patients emerged from both the study
group (HALS) and the controls (ELAP) based on age and
the underlying disease process. The first subset of patients
(Group A) comprised older patients whose indication for
surgery was pelvic organ prolapse or diverticular disease
with adnexectomy. The indication for the second,
younger subset of patients (Group B) was pelvic pain
secondary to endometriosis, adhesions, or both of these
(Tables 1 and 2). In addition to the overall HALS and
ELAP group analysis, Groups A and B were analyzed
separately (Table 3).
Surgical Technique
All procedures were performed by a combination of 1 to
2 of 4 attending surgeons including one minimally inva-
sive gynecologist, one urogynecologist, one minimally
invasive general surgeon, and one colorectal surgeon, and
a gynecology laparoscopic fellow was always present.
Each HALS patient was placed in a dorsal lithotomy po-
sition in Allen stirrups. Every HALS case started out as a
laparoscopic surgery with a 5-mm bladeless Xcel trocar
(Ethicon Endo-Surgery, Inc., Cincinnati, Ohio) placed di-
rectly in or just above the umbilicus and 2 lateral 11-mm
bladeless Excel trocars in each of the lateral lower quad-
rants. In the majority of cases, the decision to place a
hand-assist port was made after the case was attempted
laparoscopically. Usually dense adhesions prevented the
surgeon from continuing the case laparoscopically. After
removing the left lower quadrant 11-mm port, a 5.5-cm to
7-cm left lower quadrant incision was made approxi-
mately 3 fingerbreadths above the anterior superior iliac
spine, lateral to the rectus muscles, and the hand-assist
port device (LAPDISC and Ethicon Endo-Surgery, USA)
was inserted. The surgeon was then able to complete the
surgery using standard laparoscopic techniques with the
additional help of the intraperitoneal hand.
RESULTS
Patient characteristics and outcomes of both HALS pa-
tients and ELAP patients (controls) are given in Tables 3
and 4. Statistical analysis is presented in Table 5.
Figure 1. HALS Setup. 5-mm laparoscope placed just above (or
into) umbilicus. Hand-assist port in left lower quadrant with
surgeon’s nondominant (left) hand placed in port with iris valve
turned to maintain pneumoperitoneum. Right lower quadrant
port with traditional 11-mm trocar is controlled by the surgeon’s
dominant (right) hand or an assistant.
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JSLS (2010)14:70–79 75HALS patients naturally fell into 2 groups based on age
and underlying disease process. Patients in Group A
(n5) were older with a mean age of 65 years, and all had
either pelvic organ prolapse or diverticular disease as their
underlying disease. Patients in Group B (n7) were
younger with a mean age of 32 years, and all suffered from
pelvic pain due to endometriosis, adhesions, or both. The
mean ages of the 2 groups were statistically significant
(P0.001), and no overlap in the underlying disease pro-
cess existed between the groups. All other comparisons
between Group A HALS and Group B HALS patients were
not significant.
The 2 surgical techniques, ELAP and HALS were com-
pared first by analyzing Group A and Group B separately.
As expected, comparison of ELAP patients in Group A and
Group B showed differences in age and underlying dis-
ease process (data not shown). The indications and types
of surgical procedures performed in each group were
similar and are listed in Tables 1 and 2.
In Group A, 2 of the HALS cases were performed with the
help of a general surgeon, and 4 of the ELAP cases were
performed with the help of a colorectal specialist. There
was no statistical difference in hospital stay, operative
time, or average pain scores in the HALS cases when
compared with the ELAP controls.
The majority of patients in Group B had undergone mul-
tiple surgeries in the past. Six of the 7 HALS cases were
performed in conjunction with one general surgeon. The
same general surgeon assisted in 7 of 8 of the ELAP cases.
There was no difference in the postoperative drop in
hematocrit, operative (OR) time, or average pain scores
(Table 3). The patients in Group B who underwent their
surgery via HALS had less estimated blood loss (178.6 vs.
425.0 mL, P0.01) than the ELAP controls had. The length
of hospital stay in all HALS cases vs. all ELAP controls was
significant (2.9 vs. 5.4 days, P0.04). Complications in
Group B included 1 HALS patient and 2 ELAP patients
who required intraoperative blood transfusions of 2 units
of packed red blood cells each.
Because age and the underlying disease process were the
only significant differences between Group A HALS pa-
tients and Group B HALS patients, the 2 groups were
combined for subsequent comparison with the ELAP
(control) patients. When analyzed overall, the HALS pa-
tients had a shorter hospital stay (3.3 vs. 4.5 days,
P0.035) and less estimated blood loss (175.0 vs. 355.9
mL, P0.021) than the ELAP controls had (Table 3).N o
other differences reached significance.
T
a
b
l
e
4
.
(
c
o
n
t
i
n
u
e
d
)
E
x
p
l
o
r
a
t
o
r
y
L
a
p
a
r
o
t
o
m
y
(
E
L
A
P
)
P
a
t
i
e
n
t
s
(
C
o
n
t
r
o
l
s
)
P
a
t
i
e
n
t
#
G
r
o
u
p
A
g
e
(
y
e
a
r
s
)
D
i
s
e
a
s
e
S
u
r
g
e
r
y
1
°
S
u
r
g
e
o
n
2
°
S
u
r
g
e
o
n
B
M
I
*
O
R
T
i
m
e
(
m
i
n
)
E
B
L
*
D
r
o
p
i
n
H
c
t
(
m
L
)
P
a
i
n
S
c
o
r
e
(
V
A
S
)
H
o
s
p
i
t
a
l
S
t
a
y
(
d
a
y
s
)
C
o
m
p
l
i
c
a
t
i
o
n
s
1
5
B
4
1
S
t
a
g
e
4
e
n
d
o
m
e
t
r
i
o
s
i
s
T
A
H
/
B
S
O
/
c
y
s
t
o
/
s
t
e
n
t
s
/
L
O
A
/
U
r
e
t
e
r
o
l
y
s
i
s
/
I
l
e
o
c
o
l
i
c
r
e
s
e
c
t
i
o
n
/
L
A
R
/
S
i
g
m
o
i
d
o
s
c
o
p
y
G
y
n
G
e
n
S
u
r
g
2
3
2
3
2
1
0
0
0
1
8
.
3
1
.
2
7
2
U
P
R
B
C
s
1
6
B
2
7
S
t
a
g
e
4
e
n
d
o
m
e
t
r
i
o
s
i
s
E
L
A
P
/
A
p
p
e
n
d
e
c
t
o
m
y
/
L
A
R
/
L
O
A
/
R
O
v
a
r
i
a
n
c
y
s
t
e
c
t
o
m
y
/
S
m
a
l
l
b
o
w
e
l
r
e
s
e
c
t
i
o
n
/
C
y
s
t
o
/
S
t
e
n
t
s
G
e
n
S
u
r
g
G
y
n
2
8
1
4
1
2
0
0
2
.
9
3
.
8
5
1
7
B
3
1
S
t
a
g
e
4
e
n
d
o
m
e
t
r
i
o
s
i
s
T
A
H
/
B
S
O
/
c
y
s
t
o
/
s
t
e
n
t
s
/
E
x
c
i
s
i
o
n
o
f
r
e
c
t
a
l
e
n
d
o
m
e
t
r
i
o
s
i
s
G
y
n
G
e
n
S
u
r
g
2
9
2
5
3
1
0
0
0
5
.
4
2
.
1
5
2
U
P
R
B
C
s
*
B
M
I

b
o
d
y
m
a
s
s
i
n
d
e
x
;
B
S
O

b
i
l
a
t
e
r
a
l
s
a
l
p
i
n
g
o
-
o
o
p
h
o
r
e
c
t
o
m
y
;
B
x

b
i
o
p
s
y
;
C
y
s
t
o

c
y
s
t
o
s
c
o
p
y
;
E
B
L

e
s
t
i
m
a
t
e
d
b
l
o
o
d
l
o
s
s
;
E
n
d
o

e
n
d
o
m
e
t
r
i
o
s
i
s
;
H
A

h
a
n
d
a
s
s
i
s
t
;
H
c
t

H
e
m
a
t
o
c
r
i
t
;
L
A
R

l
e
f
t
a
n
t
e
r
i
o
r
(
c
o
l
o
n
)
r
e
s
e
c
t
i
o
n
;
L
O
A

l
y
s
i
s
o
f
a
d
h
e
s
i
o
n
s
;
L
S
O

l
e
f
t
s
a
l
p
i
n
g
o
-
o
o
p
h
o
r
e
c
t
o
m
y
;
P
O
P

p
e
l
v
i
c
o
r
g
a
n
p
r
o
l
a
p
s
e
d
;
P
R

p
o
s
t
e
r
i
o
r
r
e
p
a
i
r
;
S
B
O

s
m
a
l
l
b
o
w
e
l
o
b
s
t
r
u
c
t
i
o
n
;
S
C
H

s
u
p
r
a
c
e
r
v
i
c
a
l
h
y
s
t
e
r
e
c
t
o
m
y
;
S
U
I

s
t
r
e
s
s
u
r
i
n
a
r
y
i
n
c
o
n
t
i
n
e
n
c
e
;
S
u
r
g

s
u
r
g
e
r
y
;
T
A
H

t
o
t
a
l
a
b
d
o
m
i
n
a
l
h
y
s
t
e
r
e
c
t
o
m
y
;
T
V
T
O

t
e
n
s
i
o
n
f
r
e
e
v
a
g
i
n
a
l
t
a
p
i
n
g
o
b
t
u
r
a
t
o
r
;
V
A
S

v
i
s
u
a
l
a
n
a
l
o
g
s
c
a
l
e
.
The Role of Hand Assist Laparoscopic Surgery (HALS) in Pelvic Surgery for Nonmalignant Disease, Brotherton J et al.
JSLS (2010)14:70–79 76T
a
b
l
e
5
.
S
t
a
t
i
s
t
i
c
a
l
A
n
a
l
y
s
i
s
C
o
m
p
a
r
i
s
o
n
s
A
g
e
B
M
I
D
u
r
a
t
i
o
n
o
f
S
u
r
g
e
r
y
E
B
L
H
c
t
D
r
o
p
P
o
s
t
O
P
P
a
i
n
S
c
o
r
e
H
o
s
p
i
t
a
l
S
t
a
y
N
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
M
e
a
n

S
D
p
v
a
l
u
e
A
l
l
H
A
L
S
P
a
t
i
e
n
t
s
1
2
4
6
1
8
2
8
.
7
9
.
2
1
6
5
4
3
1
7
5
1
2
3
7
.
6
6
.
7
2
.
7
1
.
6
3
.
3
2
.
4
A
l
l
E
L
A
P
P
a
t
i
e
n
t
s
1
7
5
0
1
6
0
.
3
6
2
6
.
9
4
.
6
0
.
9
3
1
7
8
7
8
0
.
9
7
3
5
6
2
8
1
0
.
0
2
1
*
6
4
.
3
0
.
6
1
2
.
2
1
.
3
0
.
3
3
4
.
5
1
.
9
0
.
0
3
5
*
G
r
o
u
p
A
,
H
A
L
S
P
a
t
i
e
n
t
s
5
6
5
8
2
8
.
8
8
.
2
1
8
4
5
0
1
7
0
1
3
0
9
.
5
5
.
6
2
.
8
1
.
9
4
2
.
8
G
r
o
u
p
B
,
H
A
L
S
P
a
t
i
e
n
t
s
7
3
2
4

0
.
0
0
1
2
8
.
6
1
1
0
.
9
7
1
5
1
3
6
0
.
2
1
7
9
1
2
9
0
.
9
1
6
.
3
7
.
6
0
.
4
4
2
.
7
1
.
4
0
.
4
3
2
.
9
2
.
1
0
.
4
4
G
r
o
u
p
A
,
H
A
L
S
P
a
t
i
e
n
t
s
5
6
5
8
2
8
.
8
8
.
2
1
8
4
5
0
1
7
0
1
3
0
9
.
5
5
.
6
2
.
8
1
.
9
4
2
.
8
G
r
o
u
p
A
,
E
L
A
P
P
a
t
i
e
n
t
s
9
6
2
1
2
0
.
6
4
2
7
.
1
5
.
4
0
.
8
4
2
0
5
8
4
0
.
6
4
2
9
4
1
6
9
0
.
1
2
5
.
5
2
.
9
0
.
1
2
.
5
1
.
4
0
.
6
4
3
.
7
1
0
.
3
7
G
r
o
u
p
B
,
H
A
L
S
P
a
t
i
e
n
t
s
7
3
2
4
2
8
.
6
1
1
1
5
1
3
6
1
7
9
1
2
9
6
.
3
7
.
6
2
.
7
1
.
4
2
.
9
2
.
1
G
r
o
u
p
B
,
E
L
A
P
P
a
t
i
e
n
t
s
8
3
6
6
0
.
1
5
2
6
.
6
3
.
7
0
.
9
1
4
8
6
2
0
.
4
9
4
2
5
3
7
0
0
.
0
1
6
.
6
5
.
7
0
.
7
3
1
.
9
1
.
2
0
.
2
7
5
.
4
2
.
4
0
.
0
4
*
JSLS (2010)14:70–79 77Clinically significant adverse outcomes occurred in 2
Group A HALS patients who developed hernias through
their HA port sites. The first patient had a history of
asthma and had a coughing spell at home on postopera-
tive day #3. She was later readmitted with a small bowel
herniation through the hand-assist incision port site. A
small bowel resection was performed. The second patient
reported a bulge at her HALS incision site several months
after the procedure. A CT of the abdomen and pelvis did
not reveal herniation; however, the patient sought con-
sultation with a general surgeon who reinforced the inci-
sion.
DISCUSSION
It is well known that gynecologists were the pioneers of
laparoscopic surgery. However, due to the lack of famil-
iarity with the procedure and a need to standardize the
technique, most gynecologists have been slow to adopt
HALS. This study highlights certain situations where HALS
might be used as an alternative to converting to laparot-
omy. We suggest that HALS may actually be easier for the
surgeon in certain incidences, including in obese patients
with stage 4 endometriosis, obliteration of the cul de sac,
and dense adhesions. While these cases may be impossi-
ble laparoscopically, by introducing a hand into the intra-
peritoneal cavity, the surgeon may be able to perform
digital dissection while still benefiting from the superior
visualization of the laparoscope. Laparotomy incisions in
obese patients are wrought with difficulties and often
visualization is poor when a surgeon is working in a deep
pelvis. HALS allows the surgeon greater visualization,
while the patient benefits from still having a minimally
invasive procedure. The potential benefits of HALS may
outweigh the potential disadvantages.
Another potential avenue for the HALS technique is in
patients with pelvic organ prolapse. A minimally invasive
approach would likely benefit many of these patients who
tend to be older and who often present with more comor-
bidities than their younger counterparts. Furthermore, due
to the complexity of the procedure, many surgeons are
not able to complete sacral colpopexies laparoscopically.
HALS may allow the surgeon the opportunity to offer a
minimally invasive alternative to the traditional abdominal
sacral colpopexy.
This study was limited in many ways due to its’ retrospec-
tive nature, small number of patients, and lack of random-
ization. There was no statistical significance in operative
times between ELAP and HALS cases. Operative times
were no doubt influenced somewhat by the surgeon’s
experience. As gynecologists become more familiar with
the HALS technique, operative times will likely decrease
as the learning curve progresses for each surgeon. In
addition to surgeon experience, the standardization of a
HALS technique for gynecologists would also likely cut
down on operative times.
The fact that the majority of the HALS cases in this study
were performed in conjunction with a general or colorec-
tal surgeon lends to the fact that in the world of benign
gynecology, we are just learning this technique. HALS is
proving promising in the oncologic realm. Spannuth et al5
described in their ovarian cancer study removing ovarian
masses that averaged approximately 11cm. As more gy-
necologists become familiar with this technique, it may be
adopted and used in more benign gynecology cases.
This study also demonstrates that HALS provides the ad-
vantage of an approximately one-day decrease in duration
of hospital stay and a small (180mL) decrease in intraop-
erative blood loss. Estimated blood loss is often difficult to
quantify; therefore, we looked at the postoperative drop
in hematocrit. The numbers may have been affected by
the fact that all patients had preoperative bowel preps and
then received IV hydration intra- and postoperatively.
Three patients in the pelvic pain group (Group B) re-
ceived intraoperative blood transfusions, one who under-
went HALS and 2 who underwent ELAP. These blood
transfusions obviously make the postoperative hematocrit
levels inaccurate reflections of blood loss.
The reported pain scores were problematic in this retro-
spective study as well. Pain scores as recorded by the
nursing staff using the VAS were not measured in a con-
sistent manner or time frame in each patient. We were
limited to the numbers recorded. A prospective study
would definitely lead to a more accurate record of pain
scores. The pain scores were also influenced by the pa-
tients’ pain medication, which was variable throughout
the study. The ELAP patients actually had slightly lower
overall pain scores (2.2 1.3 vs 2.7 1.6, P0.33), which
was likely reflected by the fact that the majority of patients
who had a laparotomy incision were given a PCA (patient
controlled analgesia) pump postoperatively for at least 24
hours. HALS patients routinely were treated with IV and
PO pain medications as needed postoperatively. Attempts
were made to record postoperative pain medication con-
sumption in both HALS cases and their ELAP controls.
However, given the variability in the type of analgesics,
routes of administration, and accuracy in the record of
administration, it was not possible to use this parameter in
this retrospective study.
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JSLS (2010)14:70–79 78The occurrence of 2 postoperative incisional hernias
among the 12 HALS patients (incidence 17%) is concern-
ing. This high incidence could be due to one or more of
the following causes1: the left lower quadrant incision
used in these 12 patients is an inherently weak incision
site that is associated with a high postoperative hernia
rate2; the incision was not properly closed3; these 2 pa-
tients had compromised fascia; and/or4 these hernias are
just an unfortunate chance occurrence. The incision sites
were closed with 0 Vicryl in both cases. A delayed ab-
sorbable suture could be considered as a potential means
to reduce this complication. Also, moving the port-assist
device to a low midline transverse position may be an-
other potential means to consider in reducing hernia for-
mation.
It is evident that this small retrospective study has several
limitations. However, the other purpose of this study was
to introduce HALS into the world of benign gynecology
and to highlight some possible situations where surgeons
may use HALS as an alternative to laparotomy. Although
prospective, larger studies are needed, as well as stan-
dardization of the technique, HALS appears to be a prom-
ising modality in the world of benign gynecology.
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